Press release

Invitation to presentation of the year-end report 2023

February 21, 2024

Stockholm – February 21, 2024 – Oncopeptides AB (publ), a biotech company focused on difficult-to-treat cancers, will publish the report for the fourth quarter and the 2023 year-end report, at 08:00 (CET) on February 27, 2024. Investors, financial analysts, and media are invited to participate in a webcast and a subsequent Q&A session on February 27 at 09:00 CET.

The presentation will be hosted by Sofia Heigis, CEO, together with Henrik Bergentoft, CFO. The webcast will be held in English and published on the website of Oncopeptides – – in conjunction with the start of the presentation.
Information for participants
If you wish to participate via webcast please use the link below.

If you wish to participate via teleconference please register on the link below. After registration you will be provided phone numbers and a conference ID to access the conference. You can ask questions verbally via the teleconference.